P1449: SAFETY PROFILE OF KETOROLAC CONTINUOUS INFUSION IN SICKLE CELL RELATED ACUTE VASO-OCCLUSIVE CRISIS

Bibliographic Details
Main Authors:	Valeria Maria Pinto, Barbara Gianesin, Salvatore Sardo, Filippo Mazzi, Giammarco Baiardi, Sofia Menotti, Fabio Piras, Gabriele Finco, Gian Luca Forni, Lucia De Franceschi
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000972680.20038.22

Similar Items

Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease
by: Valeria Maria Pinto, et al.
Published: (2024-01-01)

Haemoglobin Ottawa, sickle cell trait and vaso‐occlusive crises
by: Cécile Bobillier, et al.
Published: (2024-02-01)

P1447: MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ITALY
by: Chuka Udeze, et al.
Published: (2023-08-01)

An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease
by: Won Jin Jeon, et al.
Published: (2023-12-01)

S266: DIFFERENT MOLECULAR VASO-OCCLUSIVE TRIGGERS STIMULATE DISTINCT VASO-OCCLUSIVE PROFILES: IN VIVO RESULTS FROM MICE WITH SICKLE CELL ANEMIA
by: Lucas F. S. Gushiken, et al.
Published: (2023-08-01)

Sickle Cell Disease: Metabolomic Profiles of Vaso-Occlusive Crisis in Plasma and Erythrocytes
by: Klétigui Casimir Dembélé, et al.
Published: (2020-04-01)

Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis
by: Melissa Day, et al.
Published: (2020-01-01)

Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis
by: Jeanne Sigalla, et al.
Published: (2021-01-01)

Lactate dehydrogenase and hemolysis index to predict vaso-occlusive crisis in sickle cell disease
by: Guillaume Feugray, et al.
Published: (2023-12-01)

P105: BLOOD MICROVESICLES AS BIOMARKERS TO PREDICT VASO-OCCLUSIVE CRISIS IN SICKLE CELL ANEMIA
by: M Chebbi, et al.
Published: (2022-01-01)

Circulating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease
by: Joanna Gemel, et al.
Published: (2022-02-01)

Determination of von Willebrand factor level in patient with sickle cell diseasein vaso‐occlusive crisis
by: Kingsley Akaba, et al.
Published: (2020-07-01)

Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises
by: Uttam Kumar Soren, et al.
Published: (2022-01-01)

Acute Pancreatitis in the Setting of Vaso-Occlusive Sickle Cell Crisis: A Rare Differential Diagnosis
by: Deebyendu Sahu, et al.
Published: (2022-05-01)

PB2508: COMPARING DEFINITIONS OF EPISODES OF VASO-OCCLUSION AS ENDPOINTS IN CLINICAL STUDIES OF SICKLE CELL DISEASE
by: Franco Locatelli, et al.
Published: (2023-08-01)

Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion
by: Yunfeng Liu, et al.
Published: (2023-09-01)

Fat Embolization Syndrome Secondary to Steroid Treatment in a Case of Sickle Cell Vaso-Occlusive Crisis
by: Ram Prakash Thirugnanasambandam, et al.
Published: (2023-01-01)

Subdissociative-dose ketamine for sickle cell vaso-occlusive crisis: a narrative review for the emergency physician
by: Mohammad H. Bawany, et al.
Published: (2022-09-01)

Risk factors for acute chest syndrome among children with sickle cell anemia hospitalized for vaso-occlusive crises
by: Faisal A. Alghamdi, et al.
Published: (2024-03-01)

Enhancing the Management of Pediatric Sickle Cell Disease by Integrating Functional Evaluation to Mitigate the Burden of Vaso-Occlusive Crises
by: Paul Muteb Boma, et al.
Published: (2024-03-01)

PB2511: CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN GERMANY
by: Chuka Udeze, et al.
Published: (2023-08-01)

The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease
by: Julio Delgado, et al.
Published: (2021-07-01)

PI-10: DIETARY IRON RESTRICTION PROTECTS AGAINST VASO-OCCLUSION AND ORGAN DAMAGE IN SICKLE CELL DISEASE
by: LI H., et al.
Published: (2022-08-01)

The government of the Palatinate, 1449-1508
by: Cohn, H
Published: (1963)

5599344 IMPACT OF HOSPITAL ADMISSION FOR VASO-OCCLUSIVE CRISIS ON HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH SICKLE CELL DISEASE
by: C. Vuong, et al.
Published: (2023-04-01)

P1443: INTRAVENOUS FLUID REPLACEMENT THERAPY AND HOSPITAL OUTCOMES FOR VASO-OCCLUSIVE EPISODES IN PATIENTS WITH SICKLE CELL DISEASE
by: Abraham Haimed, et al.
Published: (2023-08-01)

TGF-β1 Reduces Neutrophil Adhesion and Prevents Acute Vaso-Occlusive Processes in Sickle Cell Disease Mice
by: Lidiane S. Torres, et al.
Published: (2022-04-01)

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence
by: Thomas Gentinetta, et al.
Published: (2022-01-01)

Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises
by: Camille Boisson, et al.
Published: (2022-02-01)

The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
by: John D. Belcher, et al.
Published: (2023-04-01)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
by: Julien Demagny, et al.
Published: (2021-01-01)

P1433: POSITRON EMISSION TOMOGRAPHY IMAGING OF VLA-4 AS A NEW BIOMARKER OF VASO-OCCLUSION IN SICKLE CELL DISEASE
by: Qin Zhu, et al.
Published: (2023-08-01)

Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
by: Angie Mae Rodday, et al.
Published: (2020-11-01)

Early Administration of Intravenous Hydration and Opioid Analgesics Is Correlated with Decreased Admission Rates during Vaso-Occlusive Episodes in Sickle Cell Disease
by: Bowon Joung, et al.
Published: (2024-03-01)

PB2227: HEALTH-RELATED QUALITY OF LIFE OVER TIME IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE ADMITTED FOR VASO-OCCLUSIVE CRISIS.
by: C. Vuong, et al.
Published: (2022-06-01)

Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
by: Valeria Maria Pinto, et al.
Published: (2023-05-01)

Association between trauma triage and time-to-vaso-occlusive events in patients with sickle cell disease after traumatic injury: a retrospective study
by: Frances Guyette, et al.
Published: (2023-11-01)

Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory sensitivity
by: Wei Li, et al.
Published: (2024-02-01)

P-058: INFLUENCE OF HEME OXYGENASE-I GENE PROMOTER POLYMORPHISM ON THE VASO OCCLUSIVE CRISIS OF SICKLE CELL ANEMIA PATIENTS OF EASTERN INDIA
by: MEHER S., et al.
Published: (2022-08-01)

Patient and Caregiver Perspectives on Care-Seeking During a Vaso-Occlusive Crisis in Sickle Cell Disease: Results from Qualitative Interviews in Canada
by: Durgam N, et al.
Published: (2023-01-01)